Trademark: 90675409
Word
TIVDAQ
Status Date
Monday, April 29, 2024
Filing Date
Tuesday, April 27, 2021
Published for Opposition
Tuesday, February 1, 2022
Abandoned Date
Monday, April 29, 2024
5 Pharmaceutical preparations for use in humans, namely, chemotherapeutics for the treatment of diseases and conditions; Pharmaceutical preparations for use in humans, namely, biopharmaceuticals for the treatment of diseases and conditions, namely, cancer; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology
42 Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation
Dec 28, 2021
Examiners Amendment E-Mailed
Apr 30, 2021
New Application Entered
Aug 2, 2021
New Application Office Supplied Data Entered
Dec 22, 2021
Assigned To Examiner
Dec 28, 2021
Examiners Amendment -Written
Dec 28, 2021
Examiner's Amendment Entered
Dec 28, 2021
Notification Of Examiners Amendment E-Mailed
Dec 28, 2021
Approved For Pub - Principal Register
Dec 30, 2021
Assigned To Lie
Jan 12, 2022
Notification Of Notice Of Publication E-Mailed
Feb 1, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 15, 2022
Teas Change Of Correspondence Received
Feb 1, 2022
Published For Opposition
Mar 29, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 23, 2022
Sou Teas Extension Received
Aug 23, 2022
Sou Extension 1 Filed
Aug 23, 2022
Sou Extension 1 Granted
Aug 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 10, 2023
Sou Teas Extension Received
Feb 10, 2023
Sou Extension 2 Filed
Feb 10, 2023
Sou Extension 2 Granted
Aug 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 28, 2023
Sou Teas Extension Received
Jul 28, 2023
Sou Extension 3 Filed
Jul 28, 2023
Sou Extension 3 Granted
Apr 29, 2024
Abandonment - No Use Statement Filed
Apr 29, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
